Brief: Adicet Bio Q1 Basic EPS USD -1.88
13/05/2026 21:01
May 13 (Reuters) - Adicet Bio Q1 operating expenses USD 21.57 million. Q1 operating income USD -21.57 million Q1 net income USD -20.244 million
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary